13 Mar 2019 13:50
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Mazen Darwazah | ||||
2 | Reason for the notification | |||||
a) | Position/status | Executive Vice Chairman | ||||
b) | Initial notification /Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Hikma Pharmaceuticals PLC | ||||
b) | LEI | 549300BNS685UXH4JI75 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 | ||||
b) | Nature of the transaction
| Market purchase of 20,000 Ordinary Shares by Capital Investment & Brokerage / Jordan Ltd. Co for and on behalf of Mazen Darwazah. | ||||
c) | Price(s) and volume(s) | Price(s): £15.8198 Volume(s): 20,000 | ||||
d) | Aggregated information - Volume - Price |
£316,396.00 | ||||
e) | Date of the transaction | 13 March 2019 | ||||
f) | Place of the transaction | London Stock Exchange (XLON) | ||||
Peter SpeirsCompany Secretary, responsible for releasing this announcement+44 (0) 20 7399 2760
13 March 2019
Hikma Pharmaceuticals (HIK)